Database Query Results : , , JAK3
JAK3, Janus kinase 3: Click to Expand ⟱
| Source: CGL-Driver Genes |
| Type: Oncogene |
A member of the Janus kinase family of enzymes, which play a crucial role in the signaling pathways of various cytokines and growth factors. JAK3 is primarily expressed in hematopoietic (blood-forming) cells and is involved in the signaling of several interleukins, particularly those that are important for immune function.
Mutations in the JAK3 gene can lead to constitutive activation of the pathway, promoting uncontrolled cell proliferation and survival.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Thyroid, |
BCPAP |
|
|
|
- |
in-vitro, |
Thyroid, |
TPC-1 |
|
|
|
TumCI↓, TumCI↓, MMP2↓, MMP9↓, EMT↓, STAT3↓, miR-301a-3p↓, STAT↓, N-cadherin↓, Vim↓, Fibronectin↓, p‑JAK↓, p‑JAK2↓, p‑JAK3↓, p‑STAT1↓, p‑STAT2↓, E-cadherin↑,
PDGF↓, FLT3↓, JAK3↓, MET↓, RET↓, FGFR2↓, other↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Kinase & Signal Transduction ⓘ
RET↓, 1,
Transcription & Epigenetics ⓘ
other↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, FGFR2↓, 1, FLT3↓, 1, STAT↓, 1, p‑STAT1↓, 1, p‑STAT2↓, 1, STAT3↓, 1,
Migration ⓘ
E-cadherin↑, 1, Fibronectin↓, 1, MET↓, 1, miR-301a-3p↓, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, PDGF↓, 1, TumCI↓, 2, Vim↓, 1,
Immune & Inflammatory Signaling ⓘ
p‑JAK↓, 1, p‑JAK2↓, 1, JAK3↓, 1, p‑JAK3↓, 1,
Total Targets: 23
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: JAK3, Janus kinase 3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:165 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page